HIF‐1α mediates CXCR4 transcription to activate the AKT/mTOR signaling pathway and augment the viability and migration of activated B cell‐like diffuse large B‐cell lymphoma cells
Molecular Carcinogenesis · 2023
DOI: 10.1002/mc.23515 ↗At a glance
Journal article in Molecular Carcinogenesis, 2023. Written by Zhen Jin and 4 co-authors. Institution: Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin H…. Major MEDLINE topics: Hypoxia-Inducible Factor 1, alpha Subunit, Lymphoma, Large B-Cell, Diffuse, Receptors, CXCR4. Cited 17 times so far (Crossref); 26 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Diffuse large B‐cell lymphoma (DLBCL) is the most common lymphoid malignancy with a high relapse rate. We previously found that C‐X‐C motif chemokine receptor 4 (CXCR4) was highly expressed in DLBCL and associated with poor prognosis. This study focused on the effect of hypoxia‐inducible factor‐1α (HIF‐1α) on CXCR4 expression and the DLBCL progression. Two activated B cell‐like DLBCL cell lines Ly‐3 and SUDHL2 were transfected with overexpression and knockdown plasmids or HIF‐1α. The viability and migration of DLBCL cells were significantly increased under hypoxic conditions, or upon HIF‐1α overexpression under normoxic conditions, but the HIF‐1α downregulation led to inverse trends. However, the promoting effects of HIF‐1α overexpression on DLBCL cells were suppressed by Plerixafor (a CXCR4 inhibitor). The luciferase and chromatin immunoprecipitation assays revealed that HIF‐1α bound to the functional site HRE1 on CXCR4 promoter to activate its transcription. HIF‐1α‐mediated CXCR4 activation further led to increased phosphorylation of AKT/mTOR under hypoxic conditions. Taken together, this work reports that HIF‐1α promotes viability and migration of activated B cell‐like cells under hypoxia, which might involve the transcription of CXCR4 and the activation of the AKT/mTOR pathway. The finding may provide novel lights in the management of DCBCL.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine…
- Department of General Practice, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Faculty of Medical Laboratory Science, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Cite
APA
Jin, Z., Xiang, R., Dai, J., Wang, Y., & Xu, Z. (2023). HIF‐1α mediates CXCR4 transcription to activate the AKT/mTOR signaling pathway and augment the viability and migration of activated B cell‐like diffuse large B‐cell lymphoma cells. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23515
Vancouver
Jin Z, Xiang R, Dai J, Wang Y, Xu Z. HIF‐1α mediates CXCR4 transcription to activate the AKT/mTOR signaling pathway and augment the viability and migration of activated B cell‐like diffuse large B‐cell lymphoma cells. Molecular Carcinogenesis. 2023. doi:10.1002/mc.23515
BibTeX
@article{Jin2023,
author = {Jin, Zhen and Xiang, Rufang and Dai, Jianmin and Wang, Yefei and Xu, Zizhen},
title = {HIF‐1α mediates CXCR4 transcription to activate the AKT/mTOR signaling pathway and augment the viability and migration of activated B cell‐like diffuse large B‐cell lymphoma cells},
journal = {Molecular Carcinogenesis},
year = {2023},
doi = {10.1002/mc.23515}
}
EUVIMED